Description

Captopres (captopril) tablets №20

Ingredients:

Each tablet contains: Captopril 25mg.

Dosage:

The usual starting dose is 25mg two or three times a day. Dosage may be adjusted according to the individual’s response.

Indications:

Captopres tablets are indicated for the treatment of hypertension, heart failure, and to improve survival after a heart attack.

Contraindications:

Do not use Captopres if you are pregnant, have a history of angioedema related to previous ACE inhibitor therapy, or have severe kidney disease.

Directions:

Take Captopres tablets orally with or without food as directed by your doctor. It is important to take it regularly to get the most benefit from it.

Scientific Evidence:

Captopril, the active ingredient in Captopres tablets, is a well-studied ACE inhibitor with proven efficacy in the management of hypertension and heart failure. Research published in the Journal of the American College of Cardiology has shown that captopril significantly reduces mortality and morbidity in patients with heart failure. Additionally, a study in the New England Journal of Medicine demonstrated the effectiveness of captopril in improving outcomes post-myocardial infarction.

Additional Information:

Captopres tablets are known for their fast onset of action, making them a valuable option in the acute management of hypertension and heart failure. It is important to monitor blood pressure and kidney function regularly while on captopril therapy to ensure optimal outcomes.

Pharmacological Effects: Captopril works by inhibiting the angiotensin-converting enzyme (ACE), leading to vasodilation and reduced aldosterone secretion. This mechanism helps lower blood pressure and improve cardiac function.

Clinical Trials: Clinical trials have demonstrated the superiority of captopril over other antihypertensive agents in certain patient populations, particularly those with heart failure. Comparative studies have shown that captopril offers unique benefits in terms of cardiovascular outcomes and overall survival rates.